Faculty Bibliography

Try a new search

Format these results:

Searched for:

in-biosketch:true

person:addrid01

Total Results:

93

Chest. 2025:167(5):1285-1286.DOI: 10.1016/j.chest.2024.11.031

APCCMPD and CHEST Medical Educator Scholar Fellowship: A Novel Mechanism to Build Diverse Medical Educators [Editorial]

Kreider, Mary Elizabeth; Burkart, Kristin M; Reitzner, Joyce; Frank, James A; Buckley, Jack; Addrizzo-Harris, Doreen
PMID: 40348514
ISSN: 1931-3543
CID: 5871952
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2025:211.DOI:

Lower Airway Dysbiosis Predict Disease Phenotype in NTM-Lung Disease [Meeting Abstract]

Erlandson, K.; Collazo, D.; Mangalick, K.; Barnett, C. R.; Atandi, I.; Darawshy, F.; Li, Y.; Mccormick, C.; Czachor, A.; Basavaraj, A.; Kamelhar, D. L.; Wu, B. G.; Sulaiman, I.; Addrizzo-Harris, D. J.; Segal, L. N.; Singh, S.
ISI:001498625600012
ISSN: 1073-449x
CID: 5963592
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2025:211.DOI:

Distinct Air Pollutant Exposures in Patients With Bronchiectasis Are Associated With Differences in Airway Microbiome [Meeting Abstract]

Atandi, I.; Flowers, R. C.; Imperato, A. E.; Erlandson, K.; Collazo, D.; Barnett, C. R.; Rodriguez, C.; Krolikowski, K.; Porter, G.; Feng, Y.; Kyeremateng, Y.; Mccormick, C.; Czachor, A.; Schluger, R.; Chang, M.; Darawshy, F.; Sulaiman, I.; Li, Y.; Wu, B. G.; Gordon, T.; Thurston, G. D.; Kamelhar, D. L.; Addrizzo-Harris, D. J.; Basavaraj, A.; Singh, S.; Segal, L. N.
ISI:001488492600040
ISSN: 1073-449x
CID: 5963612
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2025:211.DOI:

Lower Airway Dysbiosis in Nontuberculous Mycobacterial Lung Disease Drives a Neutrophil Extracellular Trap-endotype and Lung Injury [Meeting Abstract]

Singh, S.; Li, Q.; Kumar, S.; Patel, S.; Narayana, J.; Darawshy, F.; Collazo, D.; Li, Y.; Atandi, I.; Kyeremateng, Y.; Chang, M.; Mccormick, C.; Schluger, R.; Czachor, A.; Lukovnikova, A.; Gomez, S.; Chung, C. J.; Kugler, M.; Tsay, J. J.; Sulaiman, I.; Basavaraj, A.; Kamelhar, D. L.; Addrizzo-Harris, D. J.; Wu, B. G.; Chalmers, J. D.; Chotirmall, S. H.; Segal, L. N.
ISI:001487774900037
ISSN: 1073-449x
CID: 5963602
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2025:211.DOI:

Socioeconomic and Racial Disparities in Patients With Acute Exacerbations of Bronchiectasis: Insights From the New York City Public Hospital System [Meeting Abstract]

Flowers, R. C.; Imperato, A. E.; Mangalick, K.; Singh, S.; Addrizzo-Harris, D. J.; Segal, L. N.; Basavaraj, A.
ISI:001489979900001
ISSN: 1073-449x
CID: 5963562
American journal of respiratory & critical care medicine. 2024:210(1):108-118.DOI: 10.1164/rccm.202307-1165OC

Five-Year Outcomes among U.S. Bronchiectasis and NTM Research Registry Patients

Aksamit, Timothy R; Locantore, Nicholas; Addrizzo-Harris, Doreen; Ali, Juzar; Barker, Alan; Basavaraj, Ashwin; Behrman, Megan; Brunton, Amanda E; Chalmers, Sarah; Choate, Radmila; Dean, Nathan C; DiMango, Angela; Fraulino, David; Johnson, Margaret M; Lapinel, Nicole C; Maselli, Diego J; McShane, Pamela J; Metersky, Mark L; Miller, Bruce E; Naureckas, Edward T; O'Donnell, Anne E; Olivier, Kenneth N; Prusinowski, Elly; Restrepo, Marcos I; Richards, Christopher J; Rhyne, Gloria; Schmid, Andreas; Solomon, George M; Tal-Singer, Ruth; Thomashow, Byron; Tino, Gregory; Tsui, Kevin; Varghese, Sumith Abraham; Warren, Heather E; Winthrop, Kevin; Zha, Beth Shoshanna
PMID: 38668710
ISSN: 1535-4970
CID: 5697642
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2024:209.DOI:

Bellevue Bronchiectasis Clinic: A Unique New York City Public Hospital Experience [Meeting Abstract]

Ramanathan, R.; Imperato, A. E.; Addrizzo-Harris, D. J.; Segal, L. N.; Singh, S.; Mcguire, E. L.; Iskandir, C.; Huang, M.; Atandi, I.; Basavaraj, A.
ISI:001277228903207
ISSN: 1073-449x
CID: 5963512
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2024:209.DOI:

Disease Phenotype in Bronchiectasis (NTM- and NTM plus ) Is Associated With Lower Airway Dysbiosis and Neutrophil Extracellular Traps [Meeting Abstract]

Singh, S.; Darawshy, F.; Narayana, J.; Erlandson, K.; Collazo, D.; Krolikowski, K.; Atandi, I.; Li, Y.; Macaogain, M.; Chang, M.; Kugler, M. C.; Natalini, J. G.; Singh, R.; Mccormick, C.; Kyeremateng, Y.; Schluger, R.; Ramanathan, R.; Basavaraj, A.; Kamelhar, D. L.; Addrizzo-Harris, D. J.; Wu, B.; Chalmers, J.; Chotirmall, S. H.; Segal, L. N.
ISI:001277228900033
ISSN: 1073-449x
CID: 5963482
Chronic obstructive pulmonary diseases. 2023:10(4):450-516.DOI: 10.15326/jcopdf.2023.0464

The 6th World Bronchiectasis and Nontuberculous Mycobacteria Conference Abstract Presentations

Aksamit, Timothy R; Emery, Elizabeth J; Basavaraj, Ashwin; Metersky, Mark L; O'Donnell, Anne E; Addrizzo-Harris, Doreen J
PMCID:10699488
PMID: 37879732
ISSN: 2372-952x
CID: 5736312
Open forum infectious diseases. 2023:10(7).DOI: 10.1093/ofid/ofad335

Long-term Safety and Tolerability of Omadacycline for the Treatment of Mycobacterium abscessus Infections

Mingora, Christina M; Bullington, Wendy; Faasuamalie, Paige E; Levin, Adrah; Porter, Gabriella; Stadnick, Ryan; Varley, Cara D; Addrizzo-Harris, Doreen; Daley, Charles L; Olivier, Kenneth N; Winthrop, Kevin L; Dorman, Susan E; Flume, Patrick A
BACKGROUND/UNASSIGNED: METHODS/UNASSIGNED:infections. All patients treated with omadacycline as part of a multidrug therapeutic regimen through December 2021 were included. Clinical data from time of omadacycline initiation and up to 12 months of follow-up were collected. Descriptive statistics were performed. RESULTS/UNASSIGNED:. In isolates with reported drug susceptibility testing, 15 of 70 (21.4%) had confirmed susceptibility to macrolides. The most common site of infection was lungs. Median duration omadacycline treatment was 8 months (range, 0.25-33 months; interquartile range, 4-15 months). Omadacycline was discontinued in 60 patients (51.3%); 20 completed planned treatment course, 23 experienced intolerance or adverse event leading to drug cessation, and 17 stopped due to cost, death (unrelated to NTM infection or therapy), or another reason. In those with pulmonary disease, 44 of 95 (46%) had 1 or more negative cultures at time of final microbiological assessment, with 17 of 95 (18%) achieving culture conversion. CONCLUSIONS/UNASSIGNED:infections.
PMCID:10354853
PMID: 37476076
ISSN: 2328-8957
CID: 5536092